Prosecution Insights
Last updated: October 04, 2026

Hypericum Lifescience GmbH

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Hypericum Lifescience GmbH currently has 1 pending office action in its patent portfolio. This action is assigned to 1 distinct examiner, KUCHARCZK, JED A. The data shows that there are 0 distinct art units associated with this pending action.

KUCHARCZK, JED A is the busiest examiner for the company, currently overseeing 1 pending office action. This 1 action represents the total pending workload for Hypericum Lifescience GmbH. Practitioners should tailor their strategy to the specific requirements of KUCHARCZK, JED A, as this is the sole point of contact for the company's active prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KUCHARCZK, JED A 1 80.2% +16.7%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18829816 HYPERICIN-PVP COMPLEX WITH HIGH HYPERICIN CONTENT KUCHARCZK, JED A —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18829816 HYPERICIN-PVP COMPLEX WITH HIGH HYPERICIN CONTENT KUCHARCZK, JED A —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18829816 HYPERICIN-PVP COMPLEX WITH HIGH HYPERICIN CONTENT KUCHARCZK, JED A — §112 Non-Final OA — Pending Sep 10, 2024

Managing Hypericum Lifescience GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month